Page last updated: 2024-10-23

bisoprolol and Dermatitis Medicamentosa

bisoprolol has been researched along with Dermatitis Medicamentosa in 3 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Asano, A1
Nakai, K1
Tsuruta, D1
Higashiyama, A1
Yokoyama, T1
Omoto, Y1
Habe, K1
Yamanaka, K1
Mizutani, H1
Giner Esparza, MA1
Miedes Pitarch, E1
Miquel Miquel, FJ1
Palop Larrea, V1

Other Studies

3 other studies available for bisoprolol and Dermatitis Medicamentosa

ArticleYear
Lichenoid drug eruption associated with bisoprolol transdermal patches.
    Contact dermatitis, 2022, Volume: 86, Issue:2

    Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Delayed-Action Prepar

2022
Flutamide-induced photoleukomelanoderma.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; B

2016
[Fixed drug eruption and bisoprolol].
    Atencion primaria, 2009, Volume: 41, Issue:6

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Drug Eruptions; Female; Humans; Middle Aged

2009